New Research Finds Annual Cost of Autism Has More Than Tripled to $126 Billion in the U.S. and Reached £34 Billion in the U.K. https://www.autismspeaks.org/press-release/new-research-finds-annual-cost-autism-has-more-tripled-126-billion-us-and-reached, 2012, Accessed Date Accessed 2012 Accessed.

Zoghbi HY, Bear MF. Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol. 2012;4:a009886.

PubMed  PubMed Central  Google Scholar 

Guang S, Pang N, Deng X, Yang L, He F, Wu L, et al. Synaptopathology involved in autism spectrum disorder. Front Cell Neurosci. 2018;12:470–470.

CAS  PubMed  PubMed Central  Google Scholar 

Lepeta K, Lourenco MV, Schweitzer BC, Martino Adami PV, Banerjee P, Catuara-Solarz S, et al. Synaptopathies: synaptic dysfunction in neurological disorders—A review from students to students. J Neurochem. 2016;138:785–805.

CAS  PubMed  PubMed Central  Google Scholar 

Institute of Medicine Forum on N, Nervous System D. The National Academies Collection: Reports funded by National Institutes of Health. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. National Academies Press (US) Copyright © 2011, National Academy of Sciences.: Washington (DC), 2011.

Choudhury PR, Lahiri S, Rajamma U. Glutamate mediated signaling in the pathophysiology of autism spectrum disorders. Pharm Biochem Behav. 2012;100:841–9.

CAS  Google Scholar 

Mahan VL Neurointegrity and neurophysiology: astrocyte, glutamate, and carbon monoxide interactions. Med Gas Res. 2019; 9: 24-45.

Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, et al. Glutamate receptor ion channels: structure, regulation, and function. Pharm Rev. 2010;62:405–96.

CAS  PubMed  PubMed Central  Google Scholar 

Tao W, Ma C, Bemben MA, Li KH, Burlingame AL, Zhang M, et al. Mechanisms underlying the synaptic trafficking of the glutamate delta receptor GluD1. Mol Psychiatry. 2019;24:1451–60.

CAS  PubMed  Google Scholar 

Gabriel L, Lvov A, Orthodoxou D, Rittenhouse AR, Kobertz WR, Melikian HE. The acid-sensitive, anesthetic-activated potassium leak channel, KCNK3, is regulated by 14-3-3β-dependent, protein kinase C (PKC)-mediated endocytic trafficking. J Biol Chem. 2012;287:32354–66.

CAS  PubMed  PubMed Central  Google Scholar 

Crupi R, Impellizzeri D, Cuzzocrea S. Role of metabotropic glutamate receptors in neurological disorders. Front Mol Neurosci. 2019;12:20.

CAS  PubMed  PubMed Central  Google Scholar 

Fritsch B, Reis J, Gasior M, Kaminski RM, Rogawski MA. Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. J Neurosci. 2014;34:5765–75.

PubMed  PubMed Central  Google Scholar 

Ronesi JA, Collins KA, Hays SA, Tsai N-P, Guo W, Birnbaum SG, et al. Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome. Nat Neurosci. 2012;15:431–S431.

CAS  PubMed  PubMed Central  Google Scholar 

Ade KK, Wan Y, Hamann HC, O’Hare JK, Guo W, Quian A, et al. Increased metabotropic glutamate receptor 5 signaling underlies obsessive-compulsive disorder-like behavioral and striatal circuit abnormalities in mice. Biol Psychiatry. 2016;80:522–33.

CAS  PubMed  PubMed Central  Google Scholar 

D’Antoni S, Spatuzza M, Bonaccorso CM, Musumeci SA, Ciranna L, Nicoletti F, et al. Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism. Neurosci Biobehav Rev. 2014;46:228–41.

PubMed  PubMed Central  Google Scholar 

Mehta MV, Gandal MJ, Siegel SJ. mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism. PLoS One. 2011;6:e26077–e26077.

CAS  PubMed  PubMed Central  Google Scholar 

Fatemi SH, Folsom TD, Kneeland RE, Liesch SB. Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both Fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism. Anat Rec (Hoboken). 2011;294:1635–45.

CAS  Google Scholar 

Fatemi SH, Folsom TD. Dysregulation of fragile × mental retardation protein and metabotropic glutamate receptor 5 in superior frontal cortex of individuals with autism: a postmortem brain study. Mol Autism. 2011;2:6–6.

PubMed  PubMed Central  Google Scholar 

Lohith TG, Osterweil EK, Fujita M, Jenko KJ, Bear MF, Innis RB. Is metabotropic glutamate receptor 5 upregulated in prefrontal cortex in fragile X syndrome? Mol Autism. 2013;4:15–15.

CAS  PubMed  PubMed Central  Google Scholar 

Darnell JC, Van Driesche SJ, Zhang C, Hung KYS, Mele A, Fraser CE, et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell. 2011;146:247–61.

CAS  PubMed  PubMed Central  Google Scholar 

Till SM, Li H-L, Miniaci MC, Kandel ER, Choi Y-B. A presynaptic role for FMRP during protein synthesis-dependent long-term plasticity in Aplysia. Learn Mem. 2010;18:39–48.

PubMed  Google Scholar 

Berry-Kravis E. Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome. Pediatr Neurol. 2014;50:297–302.

PubMed  Google Scholar 

Autism Genome Project C, Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet. 2007;39:319–28.

Google Scholar 

Jacob S, Brune CW, Badner JA, Ernstrom K, Courchesne E, Lord C, et al. Family-based association testing of glutamate transporter genes in autism. Psychiatr Genet. 2011;21:212–3.

PubMed  PubMed Central  Google Scholar 

Gadow KD, Roohi J, DeVincent CJ, Kirsch S, Hatchwell E. Glutamate transporter gene (SLC1A1) single nucleotide polymorphism (rs301430) and repetitive behaviors and anxiety in children with autism spectrum disorder. J Autism Dev Disord. 2010;40:1139–45.

PubMed  PubMed Central  Google Scholar 

Ramoz N, Reichert JG, Smith CJ, Silverman JM, Bespalova IN, Davis KL, et al. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am J Psychiatry. 2004;161:662–9.

PubMed  Google Scholar 

Ménard C, Quirion R. Group 1 metabotropic glutamate receptor function and its regulation of learning and memory in the aging brain. Front Pharm. 2012;3:182–182.

Google Scholar 

Olive MF. Metabotropic glutamate receptor ligands as potential therapeutics for addiction. Curr Drug Abus Rev. 2009;2:83–98.

CAS  Google Scholar 

Xu J, Zhu Y, Contractor A, Heinemann SF. mGluR5 has a critical role in inhibitory learning. J Neurosci. 2009;29:3676–84.

CAS  PubMed  PubMed Central  Google Scholar 

Steckler T, Oliveira AFM, Van Dyck C, Van Craenendonck H, Mateus AMA, Langlois X, et al. Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial Water maze task. Behavioural Brain Res. 2005;164:52–60.

CAS  Google Scholar 

Naie K, Manahan-Vaughan D. Regulation by metabotropic glutamate receptor 5 of LTP in the dentate gyrus of freely moving rats: relevance for learning and memory formation. Cereb Cortex. 2004;14:189–98.

PubMed  Google Scholar 

Schwede M, Nagpal S, Gandal MJ, Parikshak NN, Mirnics K, Geschwind DH, et al. Strong correlation of downregulated genes related to synaptic transmission and mitochondria in post-mortem autism cerebral cortex. J Neurodev Disord. 2018;10:18–18.

PubMed  PubMed Central  Google Scholar 

Romero-Garcia R, Warrier V, Bullmore ET, Baron-Cohen S, Bethlehem RAI. Synaptic and transcriptionally downregulated genes are associated with cortical thickness differences in autism. Mol Psychiatry. 2019;24:1053–64.

CAS  PubMed  Google Scholar 

Chen J, Yu S, Fu Y, Li X. Synaptic proteins and receptors defects in autism spectrum disorders. Front Cell Neurosci. 2014;8:276–276.

PubMed  PubMed Central  Google Scholar 

Reichelt AC, Dachtler J The Role of Neurexins and Neuroligins in Autism. In: Fatemi SH (ed). The Molecular Basis of Autism. Springer New York: New York, NY, 2015, pp 361–81.

Ching MSL, Shen Y, Tan W-H, Jeste SS, Morrow EM, Chen X, et al. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am J Med Genet B Neuropsychiatr Genet. 2010;153B:937–47.

CAS  PubMed  PubMed Central  Google Scholar 

Vaags AK, Lionel AC, Sato D, Goodenberger M, Stein QP, Curran S, et al. Rare deletions at the neurexin 3 locus in autism spectrum disorder. Am J Hum Genet. 2012;90:133–41.

CAS  PubMed  PubMed Central  Google Scholar 

Gauthier J, Siddiqui TJ, Huashan P, Yokomaku D, Hamdan FF, Champagne N, et al. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet. 2011;130:563–73.

CAS  PubMed  PubMed Central  Google Scholar 

Camacho-Garcia RJ, Planelles MI, Margalef M, Pecero ML, Martínez-Leal R, Aguilera F, et al. Mutations affecting synaptic levels of neurexin-1β in autism and mental retardation. Neurobiol Dis. 2012;47:135–43.

CAS  PubMed  Google Scholar 

Camacho-Garcia RJ, Hervás A, Toma C, Balmaña N, Cormand B, Martinez-Mir A, et al. Rare variants analysis of neurexin-1β in autism reveals a novel start codon mutation affecting protein levels at synapses. Psychiatr Genet. 2013;23:262–6.

CAS  PubMed  Google Scholar 

Yan J, Noltner K, Feng J, Li W, Schroer R, Skinner C, et al. Neurexin 1α structural variants associated with autism. Neurosci Lett. 2008;438:368–70.

CAS  PubMed  Google Scholar 

Parente DJ, Garriga C, Baskin B, Douglas G, Cho MT, Araujo GC, et al. Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity. Am J Med Genet Part A. 2017;173:213–6.

CAS  PubMed  Google Scholar 

Nakanishi M, Nomura J, Ji X, Tamada K, Arai T, Takahashi E, et al. Functional significance of rare neuroligin 1 variants found in autism. PLOS Genet. 2017;13:e1006940.

PubMed  PubMed Central  Google Scholar 

Zhang B, Seigneur E, Wei P, Gokce O, Morgan J, Südhof TC. Developmental plasticity shapes synaptic phenotypes of autism-associated neuroligin-3 mutations in the calyx of Held. Mol Psychiatry. 2017;22:1483–91.

CAS  PubMed  Google Scholar 

Zhang C, Milunsky JM, Newton S, Ko J, Zhao G, Maher TA, et al. A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export. J Neurosci. 2009;29:10843.

CAS  PubMed  PubMed Central  Google Scholar 

Gauthier J, Bonnel A, St-Onge J, Karemera L, Laurent S, Mottron L, et al. NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. Am J Med Genet Part B: Neuropsychiatr Genet. 2005;132B:74–75.

Google Scholar 

Liu Y, Du Y, Liu W, Yang C, Liu Y, Wang H, et al. Lack of association between NLGN3, NLGN4, SHANK2 and SHANK3 gene variants and autism spectrum disorder in a Chinese population. PLoS One. 2013;8:e56639–e56639.

CAS